Amlodipinum, Atorvastatinum
| Medicinal product name | Atordapin 5 mg + 10 mg film-coated tablets |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Film-coated tablet | ||||||
| Strength | 5 mg + 10 mg | ||||||
| Information from the MAH on shortages | No information on expected shortages | ||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) Next lowest cost medicine |
||||||
| Package leaflet |  18-07-2023
|
||||||
| Summary of product characteristics | 18-07-2023
|
||||||
| ATC code | C10BX03 – Lipid modifying agents | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (10)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-01 |
 Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-02 |
Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-03 |
Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-04 |
Labelling text Jan 26, 2021 |
|
|
Is available (according to the information provided by wholesalers) (280 containers) |
Recipe Plus, Magnum Medical, Euroaptieka |
N30 (5 mg/10 mg) |
OPA/Al/PVC/Al blister |
€ 6.32 * |
14-0133-05 |
Labelling text Jan 26, 2021 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-06 |
Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-07 |
Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-08 |
Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-09 |
Labelling text Jan 26, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (5 mg/10 mg) |
OPA/Al/PVC/Al blister | 14-0133-10 |
Labelling text Jan 26, 2021 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 14-0133 |
|---|---|
| Date of authorisation | Jun 20, 2014 |
| Marketing authorisation holder, country | KRKA, d.d., Novo mesto, Slovenia |
